Levitra (Vardenafil)

Levitra (Vardenafil)

0 Reviews Sold: 0

$250.00$1,800.00

Levitra is a prescription medicine used to treat the symptoms of Erectile Dysfunction (impotence). Levitra may be used alone or with other medications.

Levitra belongs to a class of drugs called Phosphodiesterase-5 Enzyme Inhibitors.

It is not known if Levitra is safe and effective in children.

What are the possible side effects of Levitra?

Levitra may cause serious side effects including:

  • hives,
  • difficulty breathing,
  • swelling of your face, lips, tongue, or throat,
  • chest pain or pressure,
  • pain spreading to your jaw or shoulder,
  • nausea,
  • sweating,
  • vision changes,
  • sudden vision loss,
  • erection that is painful or lasts longer then 4 hours,
  • ringing in your ears,
  • sudden hearing loss,
  • irregular heartbeat,
  • swelling in your hands, ankles, or feet,
  • shortness of breath,
  • lightheadedness,
  • seizure

Get medical help right away, if you have any of the symptoms listed above.

The most common side effects of Levitra include:

  • flushing (warmth, redness, or tingly feeling),
  • stuffy nose,
  • sinus pain,
  • headache,
  • dizziness,
  • upset stomach, and
  • back pain

Tell the doctor if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of Levitra. For more information, ask your doctor or pharmacist.

DESCRIPTION

LEVITRA (vardenafil hydrochloride) is administered orally for the treatment of erectile dysfunction. This monohydrochloride salt of vardenafil is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5).

Vardenafil HCl is designated chemically as piperazine, 1-[[3-(1,4-dihydro-5-methyl-4-oxo-7-propylimidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxyphenyl]sulfonyl]-4-ethyl-, monohydrochloride and has the following structural formula:

 

 

LEVITRA® (vardenafil hydrochloride) Structural Formula Illustration

 

Vardenafil HCl is a nearly colorless, solid substance with a molecular weight of 579.1 g/mol and a solubility of 0.11 mg/mL in water.

LEVITRA is formulated as orange, round, film-coated tablets with “BAYER” cross debossed on one side and “2.5”, “5”, “10”, and “20” on the other side corresponding to 2.5 mg, 5 mg, 10 mg, and 20 mg of vardenafil, respectively. In addition to the active ingredient, vardenafil HCl, each tablet contains microcrystalline cellulose, crospovidone, colloidal silicon dioxide, magnesium stearate, hypromellose, polyethylene glycol, titanium dioxide, yellow ferric oxide, and red ferric oxide

Options
Choose an option
Clear
Add to cart
Buy Now
SKU: N/A Categories: Tag:

Levitra (Vardenafil)

Levitra (Vardenafil): LEVITRA® is an oral therapy for the treatment of erectile dysfunction. This
monohydrochloride salt of vardenafil is a selective inhibitor of cyclic guanosine
monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5).
Vardenafil HCl is designated chemically as piperazine, 1-[[3-(1,4-dihydro-5-methyl-4-oxo-7­
propylimidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxyphenyl]sulfonyl]-4-ethyl-, monohydrochloride
and has the following structural formula:
Vardenafil HCl is a nearly colorless, solid substance with a molecular weight of 579.1 g/mol
and a solubility of 0.11 mg/mL in water. LEVITRA is formulated as orange, round, filmcoated tablets with “BAYER” cross debossed on one side and “2.5”, “5”, “10”, and “20” on
the other side corresponding to 2.5 mg, 5 mg, 10 mg, and 20 mg of vardenafil, respectively.
In addition to the active ingredient, vardenafil HCl, each tablet contains microcrystalline
cellulose, crospovidone, colloidal silicon dioxide, magnesium stearate, hypromellose,
polyethylene glycol, titanium dioxide, yellow ferric oxide, and red ferric oxide.
CLINICAL PHARMACOLOGY
Mechanism of Action
Penile erection is a hemodynamic process initiated by the relaxation of smooth muscle in the
corpus cavernosum and its associated arterioles. During sexual stimulation, nitric oxide is
released from nerve endings and endothelial cells in the corpus cavernosum. Nitric oxide
activates the enzyme guanylate cyclase resulting in increased synthesis of cyclic guanosine
monophosphate (cGMP) in the smooth muscle cells of the corpus cavernosum. The cGMP in
turn triggers smooth muscle relaxation, allowing increased blood flow into the penis,
resulting in erection. The tissue concentration of cGMP is regulated by both the rates of
synthesis and degradation via phosphodiesterases (PDEs). The most abundant PDE in the
human corpus cavernosum is the cGMP-specific phosphodiesterase type 5 (PDE5); therefore,
the inhibition of PDE5 enhances erectile function by increasing the amount of cGMP.
Because sexual stimulation is required to initiate the local release of nitric oxide, the
inhibition of PDE5 has no effect in the absence of sexual stimulation.
In vitro studies have shown that vardenafil is a selective inhibitor of PDE5. The inhibitory
effect of vardenafil is more selective on PDE5 than for other known phosphodiesterases (>15­
fold relative to PDE6, >130-fold relative to PDE1, >300-fold relative to PDE11, and >1,000­
fold relative to PDE2, 3, 4, 7, 8, 9, and 10).
Pharmacokinetics
The pharmacokinetics of vardenafil are approximately dose proportional over the
recommended dose range. Vardenafil is eliminated predominantly by hepatic metabolism,
mainly by CYP3A4 and to a minor extent, CYP2C isoforms. Concomitant use with potent
CYP3A4 inhibitors such as ritonavir, indinavir, ketoconazole, as well as moderate CYP3A
inhibitors such as erythromycin results in significant increases of plasma levels of vardenafil
(see PRECAUTIONS, WARNINGS and DOSAGE AND ADMINISTRATION).

Additional Information

Options

Pack of 10, Pack of 5, Single

Reviews

There are no reviews yet.

Be the first to review “Levitra (Vardenafil)”

Your email address will not be published.